ArticleInflammation research : official journal of the European Histamine Research Society ... [et al.]2026
IL-18-associated basophil and mast cell activation in sepsis.
Article in Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundThe contributions of basophils and mast cells to sepsis immunopathology remains poorly understood. Interleukin-18 (IL-18) has established roles in innate immune activation, but its relationships with basophil and mast cell activation during sepsis have not been fully defined.
methodsWe investigated expression of IL-18Rα and activation marker CD63 on blood basophils of patients with sepsis using flow cytometry and RNA-sequencing. Sepsis mouse model and human cell lines were used to assess the effect of IL-18 on basophil and mast cell activation.
resultsClose correlations between elevated plasma IL-18 level and increased CD63, IL-18Rα and IL-18Rβ protein expression on basophils of patients with sepsis were observed. Transcriptomic analysis revealed extensive reprogramming of septic basophils, including upregulation of CD63 and IL18RAP, together with enrichment of pathways related to ribosome biogenesis, mitochondrial translation, oxidative phosphorylation, proteasome, DNA replication and cell cycle. Furthermore, we observed increased expression of CD63 and IL-18Rα on basophils and mast cells in septic mice, and IL-18 upregulated their expression and mast cell accumulation in both healthy and septic mice. Additionally, elevated plasma and peritoneal levels of IL-18, IL-5, CCL2 and tryptase were observed in septic mice. In vitro experiments demonstrated that both IL-18 and plasma from patients with sepsis induced upregulation of CD63 and IL-18Rα on KU812 and HMC-1 cell lines.
conclusionsCollectively, our findings suggest that IL-18-associated basophil and mast cell activation may participate in sepsis-related inflammation.
Indexed as
Identifiers
42839034What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.